Research at University of Wisconsin

A forum for the discussion of antibiotics as a potential therapy for MS

Research at University of Wisconsin

Postby JFH » Wed Feb 16, 2005 10:28 am

My wife brought me this cutting from UK Good Housekeeping magazine:
New MS treatment goes on trial

A common antibiotic is the latest hope for treating multiple sclerosis (MS), which affects 85,000 people in the UK. Researchers believe minocycline could be used to supress the inflammation that destroys the protective covering of nerve fibres (myelin) in MS sufferers, causing numbness and paralysis. Animal tests suggest that minocycline could suppress MS if given in the early stages. The man leading the research, Dr Ian Duncan of the University of Wisconsin, says minocycline has great potential but stresses that it shouldn't be prescribeb until the results of the human clinical trials are announced.

Now googling "Ian Duncan" minocycline brings 80 pages mostly Dec '01 references to a Phase I C/T, and a $400k NMSS grant in Apr '04. http://www.nationalmssociety.org/Research-Duncan2.asp
Does anyone know of anything more recent about his research - or did the copy of GH my wife was reading come from the dentist's waiting room ?
John
I am what I am
User avatar
JFH
Family Elder
 
Posts: 288
Joined: Sun Jul 11, 2004 3:00 pm
Location: England

Advertisement

Return to Antibiotics

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service